Human iPSC-Derived Astrocytes
Frozen astrocytes differentiated from human induced pluripotent stem cell line, SCTi003-A
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
-
ACCUTASE™Cell detachment solution
-
STEMdiff™ Astrocyte Serum-Free Maturation K...Serum-free maturation kit for generating mature cortical-type astrocytes from hPSC-derived astrocyte precursors
-
Y-27632 (Dihydrochloride)RHO/ROCK pathway inhibitor; Inhibits ROCK1 and ROCK2
-
Labeling Antibodies
Compatible antibodies for purity assessment of isolated cells
Overview
Consent has been given for both academic and commercial use of this research-use-only (RUO) product. Blood samples are ethically sourced using Institutional Review Board (IRB) or other regulatory authority-approved consent forms and protocols. For donor details and cell quality characterization of the source cell banks, refer to the Data Figures section below. For additional details, refer to the lot-specific Certificate of Analysis and Frequently Asked Questions about iPSC lines.
Data Figures
Figure 1. Human iPSC-Derived Astrocytes Exhibit High-Quality Morphology
Cryopreserved Human iPSC-Derived Astrocytes generated from SCTi003-A iPSCs were thawed and plated onto Matrigel®-coated plates at 150,000 cells/cm² in STEMdiff™ Astrocyte Serum-Free Maturation Kit. Astrocytes were incubated at 37°C and subsequently analyzed on Days 1, 3, and 7 by brightfield microscopy at 10x magnification. Astrocytes display the expected morphology, including a flattened, polygonal shape with enlarged cell bodies, and by Day 7, more pronounced stellate processes characteristic of mature astrocytes. iPSC = induced pluripotent stem cell.
Figure 2. Human iPSC-Derived Astrocytes Exhibit High Purity and Express Characteristic Glial Markers
Cryopreserved Human iPSC-Derived Astrocytes generated from SCTi003-A iPSCs were thawed and cultured using the STEMdiff™ Astrocyte Serum-Free Maturation Kit for 7 days and fixed for immunocytochemistry. (A) Day 7 astrocytes show high expression of astrocyte markers S100B (green) and GFAP (red), with low expression of the neuronal marker DCX (purple) (20× magnification, scale bar = 500 µm). (B) The percentage of cells positive for S100β, GFAP, and DCX was quantified from five images per condition across three independent experiments, expressed relative to total DAPI-positive cells. S100β was expressed in 84% of cells, GFAP in 79%, and DCX in fewer than 3%. Error bars represent standard deviation (n = 3 biological replicates). iPSC = induced pluripotent stem cell.
Figure 3. Human iPSC-Derived Astrocytes Express Expected Levels of Genes Characteristic for Astrocytes
Cryopreserved Human iPSC-Derived Astrocytes generated from SCTi003-A iPSCs were thawed and cultured using the STEMdiff™ Astrocyte Serum-Free Maturation Kit for 7 days prior to analysis. Expression levels were measured by quantitative PCR (qPCR) and normalized to hPSC controls relative to housekeeping gene TBP. iPSC = induced pluripotent stem cell; hPSC = human pluripotent stem cell.
Figure 4. Human iPSC-Derived Astrocytes Uptake Excess Glutamate In Culture, Indicating Functional Maturity
Cryopreserved Human iPSC-Derived Astrocytes generated from the SCTi003-A iPSCs were thawed and cultured in STEMdiff™ Astrocyte Serum-Free Maturation Kit for 7 days. Prior to glutamate treatment, cells were incubated in BrainPhys™ medium for 4 hours at 37°C and 5% CO₂. Cells were then treated for 1 hour with either 50 µM glutamate in BrainPhys™ ("GLU") or water in BrainPhys™ ("CTRL"). Glutamate levels in each sample were quantified using the Fluorometric Glutamate Assay Kit (Abcam, ab138883). Different colors represent distinct experimental setups. Bars represent mean ± standard deviation. (A) Glutamate concentration in the media (“Pre-Treatment”) and spent media (“Post-Treatment”). (B) Glutamate concentration in the cell lysates, extracted with Mammalian Cell Lysis Buffer (ABCAM, ab179835). iPSC = induced pluripotent stem cell.
Figure 5. Human iPSC-Derived Astrocytes Display Reactive Phenotype Upon Cytokine Stimulation
Cryopreserved Human iPSC-Derived Astrocytes generated from the SCTi003-A iPSCs were thawed and cultured in STEMdiff™ Astrocyte Serum-Free Maturation Kit for 7 days. Astrocytes were treated with either a vehicle control ("CTRL") or a pro-inflammatory cytokine cocktail ("A1") consisting of 30 ng/mL TNFα, 3 ng/mL IL-1α, and 400 ng/mL C1Qa for 24 hours. Following A1 treatment, astrocytes showed increased expression of C3 (marker of neurotoxic reactive astrocytes) and GBP2 (interferon response and inflammation marker). Expression levels were measured by quantitative PCR (qPCR) and normalized to hPSC controls relative to housekeeping gene TBP. Statistical significance was determined using an unpaired t-test (***p < 0.001). Bars represent mean ± standard deviation, with different colors indicating distinct experimental conditions. iPSC = induced pluripotent stem cell.
Figure 6. Human iPSC-Derived Astrocytes Can Be Co-Cultured with Neurons to Model Cell-Cell Interactions In Vitro
Representative immunocytochemistry images display Human iPSC-Derived Astrocytes co-cultured with forebrain neurons derived using the STEMdiff™-TF Forebrain Induced Neuron Differentiation Kit for 21 days and maintained in the STEMdiff™ Forebrain Neuron Maturation Kit. Cells were stained for GFAP (green, astrocyte marker) and MAP2 (pink, neuronal dendrite marker). The presence of MAP2-positive neurons alongside GFAP-positive astrocytes demonstrates compatibility in co-culture conditions, supporting the viability and integration of neurons within an astrocyte-rich environment. Scale bar = 100 µm.
Figure 7. Human iPSC-Derived Astrocytes Can Be Tri-Cultured with Neurons and Microglia to Model Cell-Cell Interactions In Vitro
Representative immunocytochemistry images display Human iPSC-Derived Astrocytes tri-cultured with forebrain neurons derived using the STEMdiff™-TF Forebrain Induced Neuron Differentiation Kit and microglia for 7 days using BrainPhys™ hPSC Neuron Kit supplemented with STEMdiff™ Microglia Supplement 2 (Component #100-0023 of STEMdiff™ Microglia Differentiation Kit). Cells were stained for GFAP (green, astrocyte marker), MAP2 (pink, neuronal dendrite marker), IBA1 (cyan, common microglia marker), and DAPI (grey, nuclei). The presence of MAP2-positive neurons, GFAP-positive astrocytes, and IBA1-positive microglia confirms the successful establishment of tri-culture conditions and supports the viability and integration of astrocytes in a mixed neuron–microglia environment. Scale bar = 50 µm.
Figure 8. Human iPSC-Derived Astrocytes Promote Neural Activity in Co-Culture with Human iPSC-Derived Neurons
Human iPSC-Derived Forebrain Neuron Precursor Cells (Catalog #200-0770) were cultured either alone or in a 1:1 co-culture with isogenic Human iPSC-Derived Astrocytes (Catalog #200-0980). Cells were plated on a 48-well CytoView MEA™ Plate (Catalog #200-0872) and maintained in STEMdiff™ Forebrain Neuron Maturation Medium (Catalog #08605). Electrical activity from 16 electrodes per well was recorded longitudinally using the Maestro Pro™ MEA system (Catalog #200-0887). (A - B) Representative brightfield images show the morphology of neuron-only and neuron-astrocyte co-cultures on the MEA plate. (C - D) Raster plots on Day 21 illustrate spike activity in neuron-only versus co-culture conditions. Detected spikes (black lines), single-channel bursts (blue lines; defined as ≥5 spikes with inter-spike intervals [ISI] ≤100 ms), and network bursts (≥50 spikes across ≥35% of electrodes with ISI ≤100 ms) were quantified over time. Co-cultures showed a visibly higher level of neuronal activity on Day 21 compared to neurons alone. (E - G) Quantitative analyses revealed a progressive increase in (E) mean firing rate, (F) number of active electrodes, and (G) burst frequency over the 21-day period. Across all measures, neuron-astrocyte co-cultures consistently exhibited significantly greater electrophysiological activity than neuron-only cultures. hiPSC = human induced pluripotent stem cell; MEA = microelectrode array; ISI = inter-spike interval.
Protocols and Documentation
Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.
Applications
This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.
Resources and Publications
Educational Materials (20)
Related Products
-
STEMdiff™ Astrocyte Differentiation KitSerum-free differentiation kit for generating astrocyte precursors from hPSC-derived neural progenitor cells
-
Healthy Control Human iPSC Line, Female, SCTi...Human pluripotent stem cell line, frozen
-
Human iPSC-Derived Neural Progenitor CellsFrozen human neural progenitor cells differentiated from the human induced pluripotent stem cell line, SCTi003-A
-
Human iPSC-Derived Forebrain Neuron Precursor...Frozen human forebrain neuron precursor cells differentiated from human induced pluripotent stem cell line, SCTi003-A
Item added to your cart
Human iPSC-Derived Astrocytes
These iPSCs and their modifications (including but not limited to derivatives or differentiated progeny) shall not be used or administered in (1) human subjects for human clinical use; (2) animals for veterinary use for therapeutic, diagnostic, or prophylactic purposes or (3) any subject in relation to clinical applications, cell therapy, transplantation, and/or regenerative medicines, without limiting the generality of the foregoing. These iPSCs and their modifications (including but not limited to derivatives or differentiated progeny) may not be used for monetization or commercialization purposes, including without limitation, used to, or with the goal to, perform services or supply products or rights, including in the manufacture of cellular therapies or other therapeutics, for monetary gain or the generation of royalties, revenues, sales or other valuable consideration. For clarity, these iPSCs and their modifications (including but not limited to derivatives or differentiated progeny) may not be used for screening compounds, antibodies, proteins or peptides, except for the purposes of target discovery, target validation, or assay development, provided such activities and the results of such activities are not further used for monetization or commercialization purposes. It may be possible to obtain a further license for the prohibited uses referred to in this Limited Use License. Please contact iPSCrequests@stemcell.com for more details.
PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED.